New drug trial offers hope for patients with advanced colorectal cancer
Disease control
Recruiting now
This study tests a new drug, tegavivint, in people with metastatic colorectal cancer that has worsened after at least two prior treatments. The trial aims to find a safe dose and see if the drug works alone or with standard therapies. About 126 adults aged 18 and older will take …
Phase: PHASE1, PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated May 06, 2026 16:15 UTC